Please join us on Thursday, March 25th, at noon for this month’s Levy CIMAR Science Meeting on “Innovation Solutions to AMR.” We are excited to hear from Kevin Outterson, Esq., Professor of Law at Boston University and Executive Director of the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X. CARB-X is a global partnership hosted at BU Law that is focused on supporting developers of promising new antibiotics, diagnostics, and vaccines that tackle the threat of untreatable bacterial infections.

CARB-X participants include Kevin Outterson, Executive Director.

Click here to learn more about Levy CIMAR.
Contact Rima Mycynek @ Rima.Mycynek@tufts.edu for Zoom Details.